Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996:94:1029-72.

Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways

Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways

J S Pulido. Trans Am Ophthalmol Soc. 1996.

Abstract

Purpose: To study the process of nonenzymatic glycosolation of vitreous collagen in vitro to determine the contributions of the classic Maillard pathway and the oxidative pathway, as well as to evaluate possible inhibitors of both pathways.

Methods: Bovine vitreous collagen was extracted and then incubated with hexoses in vitro. The amount of advanced glycosylation end (AGE) products was measured by fluorometry under varying conditions in the presence and absence of glycosolation inhibitors. Oxygen consumption studies and electron spin resonance spectroscopy with and without free-radical inhibitors were performed to differentiate oxidative from nonoxidative glycosolation.

Results: Vitreous collagen undergoes nonenzymatic glycosolation in the presence of glucose or galactose in vitro. Oxygen consumption data show that oxygen is consumed in glucose and galactose solutions. Oxygen consumption is decreased by known free-radical inhibitors and rutin but not aminoguanidine. Electron spin resonance spectroscopy demonstrated the presence of a carbon-centered radical, and known free-radical inhibitors decreased the carbon-centered signal.

Conclusions: Nonenzymatic glycosolation of vitreous collagen can occur not only by the classic nonoxidative pathway, but also by a second oxidative pathway that is susceptible to a number of inhibitors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Diabetes. 1983 Nov;32(11):988-92 - PubMed
    1. Diabetes. 1984 Jan;33(1):97-100 - PubMed
    1. Invest Ophthalmol Vis Sci. 1984 Mar;25(3):302-11 - PubMed
    1. Biochem J. 1984 Mar 15;218(3):835-40 - PubMed
    1. Diabetes. 1984 Jun;33(6):562-6 - PubMed

Publication types

LinkOut - more resources